lucius卢修斯 凡德他尼 Vandetanib甲状腺髓样癌

凡德他尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Vandetanib

老挝国家食药监局批准上市
老挝国家药检所检测认证

Compositioe:
uTablel contain

LUCIUS

甲状腺髓样癌

Indication:

........ 100 mng

PHARMACEUTICALS

Laci Vande is a kinase inbibitor indicated forthe
treatment of symptomatic or progressive medullar
tnyroid cancer in patients with unresectable
advanced or mabaisl .. Xssss
hnked or metastatic disease
Use LuciVande in patien

fie or slowly progressine disease only

carersl considerafion ol tha lrasimant elsted

LuciVande 100

Dosage and Use

Vandetanib Tablets

FDA批准

LuciVande may be tal
Doeesele witl or without food.
Dosage reduction may ko

Rx Only

severe toiet aya the event
or QTcisterval proleo

l a proongation.
ustate renal impairmert

100mg

Serage: in a dry plnce and store at 20°C to 25C
Keep medicine out of reach of Children. Do n
ster LaciVande doriag Pregnaney and
Lactation.

PLEASE SEE PACKAGE INSERT

权威认证

Manufactured and Marketed by:
LUCIUS

thongmang village, Xaythany district
Ventiane Capital. Laos
Warning: To be sold by retilon scaceiinfion
of registered phsicians only, and as directss

口碑质量

e paysician.

30 Tablets

适应症:
凡德他尼是一种激酶抑制剂,用于治疗无法切除的局部晚期或转移
性甲状腺髓样癌患者的症状性或进展性甲状腺髓样癌。
对于惰性、无症状或进展缓慢的患者,仅在仔细考虑凡德他尼的治疗
相关风险后,才可使用凡德他尼。
推荐剂量:
·每日一次,每次300mg。
·可与食物同服或单独服用。
·如果出现严重毒性或QTc间期延长,可能需要减少剂量。
·中度肾功能不全患者的起始剂量为200mg。